JP2021147392A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021147392A5 JP2021147392A5 JP2021035929A JP2021035929A JP2021147392A5 JP 2021147392 A5 JP2021147392 A5 JP 2021147392A5 JP 2021035929 A JP2021035929 A JP 2021035929A JP 2021035929 A JP2021035929 A JP 2021035929A JP 2021147392 A5 JP2021147392 A5 JP 2021147392A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- lipoic acid
- composition according
- choline ester
- acid choline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*(C)(CCOC(CCCCC1SSCC1)=O)COS(c1ccc(C)cc1)(=O)=O Chemical compound C*(C)(CCOC(CCCCC1SSCC1)=O)COS(c1ccc(C)cc1)(=O)=O 0.000 description 3
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021206074A JP2022058376A (ja) | 2020-03-13 | 2021-12-20 | リポ酸コリンエステル塩の医薬組成物及びそれを使用した処置方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020079271 | 2020-03-13 | ||
| CNPCT/CN2020/079271 | 2020-03-13 | ||
| US202063013836P | 2020-04-22 | 2020-04-22 | |
| US63/013,836 | 2020-04-22 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021206074A Division JP2022058376A (ja) | 2020-03-13 | 2021-12-20 | リポ酸コリンエステル塩の医薬組成物及びそれを使用した処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021147392A JP2021147392A (ja) | 2021-09-27 |
| JP2021147392A5 true JP2021147392A5 (cg-RX-API-DMAC10.html) | 2021-11-04 |
| JP7041298B2 JP7041298B2 (ja) | 2022-03-23 |
Family
ID=75108681
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021035929A Expired - Fee Related JP7041298B2 (ja) | 2020-03-13 | 2021-03-08 | リポ酸コリンエステル塩の医薬組成物及びそれを使用した処置方法 |
| JP2021206074A Pending JP2022058376A (ja) | 2020-03-13 | 2021-12-20 | リポ酸コリンエステル塩の医薬組成物及びそれを使用した処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021206074A Pending JP2022058376A (ja) | 2020-03-13 | 2021-12-20 | リポ酸コリンエステル塩の医薬組成物及びそれを使用した処置方法 |
Country Status (18)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026518762A (ja) | 2023-05-24 | 2026-06-09 | 温州医科大学附属眼視光医院 | 効果的に近視を先送りにし治療する医薬組成物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5520920A (en) | 1978-07-31 | 1980-02-14 | Honda Motor Co Ltd | Device for absorbing twisting vibration of drive system |
| US8647612B2 (en) | 2008-03-05 | 2014-02-11 | Encore Health, Llc | Dithiol compounds, derivatives, and treatment of presbyopia |
| AR050902A1 (es) * | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
| DE102006062599B4 (de) | 2006-12-29 | 2018-03-08 | Endress + Hauser Gmbh + Co. Kg | Opto-elektronische Vorrichtung zur Übertragung eines elektrischen Signals und deren Verwendung |
| WO2009038656A1 (en) | 2007-09-17 | 2009-03-26 | Kosta Steliou | Mitochondria-targeting antioxidant therapeutics |
| US9044439B2 (en) | 2008-03-05 | 2015-06-02 | Encore Health, Llc | Low dose lipoic and pharmaceutical compositions and methods |
| WO2009111635A2 (en) | 2008-03-05 | 2009-09-11 | Encore Health, Llc | Dithiol compounds, derivatives, and uses therefor |
| EP3069612A3 (en) | 2009-06-15 | 2016-10-19 | Encore Health, LLC | Dithiol compounds, derivatives, and uses therefor |
| ES2579173T3 (es) | 2009-06-15 | 2016-08-05 | Encore Health, Llc | Ésteres de colina para tratar presbicia y cataratas |
| EP3113613A4 (en) * | 2014-03-03 | 2019-03-13 | Encore Vision, Inc. | LIPOIC ACID CHOLINESTER COMPOSITIONS AND METHOD OF USE THEREOF |
| WO2016126662A1 (en) | 2015-02-03 | 2016-08-11 | Kardiatonos, Inc. | Compounds for the prevention and treatment of vascular disease |
| WO2016164534A1 (en) | 2015-04-09 | 2016-10-13 | Kardiatonos, Inc. | Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage |
| WO2016176089A1 (en) | 2015-04-29 | 2016-11-03 | Kardiatonos, Inc. | Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage |
| ES2904580T3 (es) * | 2015-09-24 | 2022-04-05 | Novartis Ag | Composiciones de éster de colina del ácido lipoico y métodos para generar formulaciones oftálmicas biocompatibles. |
| JOP20190057A1 (ar) * | 2016-09-23 | 2019-03-24 | Encore Vision Inc | تركيبات استر كولين حمض الليبويك وطرق تثبيتها إلى منتجات عقار ذات صلة دوائية |
| CN106967044B (zh) * | 2017-05-12 | 2019-02-22 | 苏州富士莱医药股份有限公司 | 制备r-硫辛酸胆碱酯卤化物的方法 |
| CN107089967A (zh) * | 2017-05-12 | 2017-08-25 | 苏州富士莱医药股份有限公司 | 一种r‑硫辛酸胆碱酯卤化物的制备方法 |
| EP3749303A4 (en) * | 2018-02-05 | 2022-01-26 | Cellixbio Private Limited | COMBINATION OF AN ANTIMUSCARINE OR ANTICCHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF |
| US11158871B2 (en) | 2018-07-18 | 2021-10-26 | GM Global Technology Operations LLC | Fuel cell assembly and a vehicle that utilizes the fuel cell assembly |
| US11985964B2 (en) | 2018-08-03 | 2024-05-21 | Kevin F Lohmeier | Fishing rod holder |
| CN108822077A (zh) | 2018-08-07 | 2018-11-16 | 苏州富士莱医药股份有限公司 | 一种r-硫辛酸胆碱酯卤化物的精制方法 |
| CN108586429A (zh) | 2018-08-07 | 2018-09-28 | 苏州富士莱医药股份有限公司 | R-硫辛酸胆碱酯卤化物的纯化精制方法 |
-
2021
- 2021-03-03 CN CN202110237490.7A patent/CN113387923A/zh active Pending
- 2021-03-08 JP JP2021035929A patent/JP7041298B2/ja not_active Expired - Fee Related
- 2021-03-11 TW TW110108635A patent/TWI768760B/zh not_active IP Right Cessation
- 2021-03-12 WO PCT/IB2021/052092 patent/WO2021181361A1/en not_active Ceased
- 2021-03-12 EP EP21713132.5A patent/EP4118079A1/en not_active Withdrawn
- 2021-03-12 PE PE2022001926A patent/PE20230242A1/es unknown
- 2021-03-12 BR BR112022018043A patent/BR112022018043A2/pt not_active Application Discontinuation
- 2021-03-12 KR KR1020227033130A patent/KR20220146561A/ko not_active Ceased
- 2021-03-12 CR CR20220449A patent/CR20220449A/es unknown
- 2021-03-12 MX MX2022011206A patent/MX2022011206A/es unknown
- 2021-03-12 CN CN202180020651.5A patent/CN115279745A/zh active Pending
- 2021-03-12 US US17/199,736 patent/US11135239B1/en active Active
- 2021-03-12 CA CA3175077A patent/CA3175077A1/en active Pending
- 2021-03-12 AU AU2021235563A patent/AU2021235563A1/en not_active Abandoned
- 2021-03-12 IL IL295378A patent/IL295378A/en unknown
- 2021-08-31 US US17/463,391 patent/US11590158B2/en active Active
- 2021-12-20 JP JP2021206074A patent/JP2022058376A/ja active Pending
-
2022
- 2022-09-06 CO CONC2022/0012653A patent/CO2022012653A2/es unknown
- 2022-09-06 EC ECSENADI202269611A patent/ECSP22069611A/es unknown
- 2022-09-07 DO DO2022000179A patent/DOP2022000179A/es unknown
- 2022-09-08 JO JOP/2022/0211A patent/JOP20220211A1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20220016304A (ko) | 중수소 농축 N-아세틸시스테인 아미드(D-NACA) 및 (2R,2R')-3,3'-디설판디일 비스(2-아세트아미도프로판아미드)(Di-NACA)의 제조방법 및 산화 스트레스를 포함하는 질환을 치료하기 위한 D-NACA 및 Di-NACA의 사용방법 | |
| JP6683622B2 (ja) | 眼科用水性組成物 | |
| JP4923141B2 (ja) | アデノシン誘導体を有効成分として含有する緑内障治療剤 | |
| JP2022017260A5 (cg-RX-API-DMAC10.html) | ||
| US20200181136A1 (en) | Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof | |
| CN102516298A (zh) | 左旋奥硝唑磷酸酯稳定的药用盐及其制备方法和用途 | |
| JP2019505596A (ja) | ５′−アデノシン二リン酸リボース（ａｄｐｒ）の使用方法 | |
| JPWO2002020540A1 (ja) | アデノシン誘導体及びその用途 | |
| JPH0427976B2 (cg-RX-API-DMAC10.html) | ||
| JP2013508272A (ja) | ブロムフェナクナトリウムの多形体、及び、ブロムフェナクナトリウム多形体の製造方法 | |
| US20160244479A1 (en) | SELECTIVE INHIBITORS OF ALPHA2 ISOFORM OF Na,K-ATPase AND USE FOR REDUCTION OF INTRA-OCULAR PRESSURE | |
| WO2017090349A1 (ja) | トリアリールメタン組成物，眼膜染色のための染色組成物 | |
| JP7041298B2 (ja) | リポ酸コリンエステル塩の医薬組成物及びそれを使用した処置方法 | |
| JP2016539994A (ja) | α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法 | |
| US5013751A (en) | (+) Suprofen esters and amides as opthalmic anti-inflammatory agents | |
| JP7016880B2 (ja) | チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤 | |
| JP5969872B2 (ja) | フラビンアデニンジヌクレオチドまたはその塩を有効成分として含有する角膜上皮細胞死の抑制剤 | |
| TW201838629A (zh) | 用於預防近視、治療近視及／或預防近視增長之包含蕪地銨作爲活性成分的藥劑 | |
| KR20140068190A (ko) | 히알루론산 및 플라빈 아데닌 디뉴클레오티드를 조합한 것을 특징으로 하는 각막상피세포사의 억제제 | |
| JP6471123B2 (ja) | トリアリールメタン組成物，眼膜染色のための染色組成物 | |
| WO2013114397A2 (en) | Pharmaceutically acceptable salt of brinzolamide and composition thereof | |
| JP2016540001A (ja) | ステロイド様化合物の多形形態並びにその製造方法及びその用途 | |
| JP2025516315A5 (cg-RX-API-DMAC10.html) | ||
| HK40016534A (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient | |
| JP2016117737A (ja) | ブロムフェナクナトリウムの多形体、及び、ブロムフェナクナトリウム多形体の製造方法 |